Thiopurine Monotherapy effective in Ulcerative Colitis, Finds study

Written By : Dr. Nandita Mohan |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2020-10-13T17:00:53+05:30 | Updated On 13 Oct 2020 5:01 PM IST

Researchers have found out that "Thiopurine is an effective long-term treatment for Ulcerative Colitis (UC) but significantly less effective in Crohn's disease (CD)", in their recent study published in the GUT.

Thiopurines are widely used as a maintenance therapy in inflammatory bowel disease (IBD) but the evidence base for their use is sparse and their role increasingly questioned.

"Using the largest series reported to date, we assessed the long-term effectiveness of thiopurines in ulcerative colitis (UC) and Crohn's disease (CD), including their impact on need for surgery", describes Evangelos Stournaras from the Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

The basic design of the study outlined by Stournaras and his colleagues included the evaluation of 11,928 patients (4968 UC, 6960 CD) in the UK IBD BioResource initiated on thiopurine monotherapy with the intention of maintaining medically induced remission.

The effectiveness was assessed retrospectively using patient-level data and a definition that required avoidance of escalation to biological therapy or surgery while on thiopurines. Analyses included overall effectiveness, time-to-event analysis for treatment escalation and comparison of surgery rates in patients tolerant or intolerant of thiopurines.

Using 68 132 patient-years of exposure, the results were formulated. It was found that thiopurine monotherapy appeared effective for the duration of treatment in 2617/4968 (52.7%) patients with Ulcerative Colitis compared with 2378/6960 (34.2%) Crohn's disease. The authors corroborated this difference in multivariable analysis and discovered that after adjusting the variables including treatment era, thiopurine monotherapy was less effective in Crohn's disease (CD), than Ulcerative Colitis (UC).

Thiopurine intolerance was associated with increased risk of surgery in UC (HR 2.44, p<0.0001); with a more modest impact on the need for surgery in Crohn's disease (CD), says Stournaras.

Asa result, the researchers concluded by saying that "Thiopurine monotherapy is an effective long-term treatment for UC but significantly less effective in CD."

acute severe ulcerative colitisCrohn

Source : GUT

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751